Literature DB >> 25594544

Antihypertensive mechanisms of intra-renal dopamine.

Ming-Zhi Zhang1, Raymond C Harris.   

Abstract

PURPOSE OF REVIEW: This review will highlight recent findings concerning the regulation and signalling of the intrarenal dopaminergic system and the emerging evidence for its importance in blood pressure regulation. RECENT
FINDINGS: There is an increasing evidence that the intrarenal dopaminergic system plays an important role in the regulation of blood pressure, and defects in dopamine signalling appear to be involved in the development of hypertension. Recent experimental models have definitively demonstrated that abnormalities in intrarenal dopamine production or receptor signalling can predispose to salt-sensitive hypertension and a dysregulated renin-angiotensin system. There are also new results indicating the importance of dopamine receptor mediated regulation of salt and water homeostasis along the nephron, and new studies indicating the role that the intrarenal dopaminergic system plays to mitigate the production of reactive oxygen species and progression of chronic renal disease.
SUMMARY: New studies underscore the importance of the intrarenal dopaminergic system in the regulation of renal function and indicate how alterations in dopamine production or signalling may underlie the development of hypertension and kidney injury.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25594544      PMCID: PMC4651846          DOI: 10.1097/MNH.0000000000000104

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  41 in total

1.  Oxidative stress alters renal D1 and AT1 receptor functions and increases blood pressure in old rats.

Authors:  Gaurav Chugh; Mustafa F Lokhandwala; Mohammad Asghar
Journal:  Am J Physiol Renal Physiol       Date:  2010-10-13

2.  Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice.

Authors:  Ming-Zhi Zhang; Bing Yao; Suwan Wang; Xiaofeng Fan; Guanqing Wu; Haichun Yang; Huiyong Yin; Shilin Yang; Raymond C Harris
Journal:  J Clin Invest       Date:  2011-06-23       Impact factor: 14.808

3.  Role of epoxyeicosatrienoic acids (EETs) in mediation of dopamine's effects in the kidney.

Authors:  Ming-Zhi Zhang; Yinqiu Wang; Bing Yao; Leslie Gewin; Shouzuo Wei; Jorge H Capdevila; Raymond C Harris
Journal:  Am J Physiol Renal Physiol       Date:  2013-10-23

4.  Regulation of glomerulotubular balance. I. Impact of dopamine on flow-dependent transport.

Authors:  Zhaopeng Du; Qingshang Yan; Laxiang Wan; Sheldon Weinbaum; Alan M Weinstein; Tong Wang
Journal:  Am J Physiol Renal Physiol       Date:  2012-05-02

5.  Upregulation of renal sodium transporters in D5 dopamine receptor-deficient mice.

Authors:  Xiaoyan Wang; Yingjin Luo; Crisanto S Escano; Zhiwei Yang; Laureano Asico; Hewang Li; John E Jones; Ines Armando; Quansheng Lu; David R Sibley; Gilbert M Eisner; Pedro A Jose
Journal:  Hypertension       Date:  2010-04-19       Impact factor: 10.190

6.  Intrarenal dopamine attenuates deoxycorticosterone acetate/high salt-induced blood pressure elevation in part through activation of a medullary cyclooxygenase 2 pathway.

Authors:  Bing Yao; Raymond C Harris; Ming-Zhi Zhang
Journal:  Hypertension       Date:  2009-09-21       Impact factor: 10.190

7.  Renalase regulates renal dopamine and phosphate metabolism.

Authors:  Daria Sizova; Heino Velazquez; Benedita Sampaio-Maia; Janete Quelhas-Santos; Manuel Pestana; Gary V Desir
Journal:  Am J Physiol Renal Physiol       Date:  2013-07-17

8.  Inhibitors of 20-hydroxyeicosatetraenoic acid (20-HETE) formation attenuate the natriuretic effect of dopamine.

Authors:  Maria M Federik Fernandez; Daniel Gonzalez; Jan M Williams; Richard J Roman; Susana Nowicki
Journal:  Eur J Pharmacol       Date:  2012-05-02       Impact factor: 4.432

9.  Sestrin2 decreases renal oxidative stress, lowers blood pressure, and mediates dopamine D2 receptor-induced inhibition of reactive oxygen species production.

Authors:  Yu Yang; Santiago Cuevas; Sufei Yang; Van Anthony Villar; Crisanto Escano; Laureano Asico; Peiying Yu; Xiaoliang Jiang; Edward J Weinman; Ines Armando; Pedro A Jose
Journal:  Hypertension       Date:  2014-07-14       Impact factor: 10.190

10.  MicroRNA 142-3p mediates post-transcriptional regulation of D1 dopamine receptor expression.

Authors:  Krishna E Tobón; Denis Chang; Eldo V Kuzhikandathil
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

View more
  31 in total

1.  Increased renal oxidative stress in salt-sensitive human GRK4γ486V transgenic mice.

Authors:  Zhenyu Diao; Laureano D Asico; Van Anthony M Villar; Xiaoxu Zheng; Santiago Cuevas; Ines Armando; Pedro A Jose; Xiaoyan Wang
Journal:  Free Radic Biol Med       Date:  2017-02-09       Impact factor: 7.376

2.  Urine metabolites are associated with glomerular lesions in type 2 diabetes.

Authors:  Pierre-Jean Saulnier; Manjula Darshi; Kevin M Wheelock; Helen C Looker; Gudeta D Fufaa; William C Knowler; E Jennifer Weil; Stephanie K Tanamas; Kevin V Lemley; Rintaro Saito; Loki Natarajan; Robert G Nelson; Kumar Sharma
Journal:  Metabolomics       Date:  2018-06-08       Impact factor: 4.290

Review 3.  New insights into sodium transport regulation in the distal nephron: Role of G-protein coupled receptors.

Authors:  Luciana Morla; Aurélie Edwards; Gilles Crambert
Journal:  World J Biol Chem       Date:  2016-02-26

Review 4.  Primary Pediatric Hypertension: Current Understanding and Emerging Concepts.

Authors:  Andrew C Tiu; Michael D Bishop; Laureano D Asico; Pedro A Jose; Van Anthony M Villar
Journal:  Curr Hypertens Rep       Date:  2017-09       Impact factor: 5.369

Review 5.  Gut microbiota in hypertension.

Authors:  Pedro A Jose; Dominic Raj
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-09       Impact factor: 2.894

Review 6.  Genomics and Pharmacogenomics of Salt-sensitive Hypertension.

Authors:  Ines Armando; Van Anthony M Villar; Pedro A Jose
Journal:  Curr Hypertens Rev       Date:  2015

7.  Gastrin stimulates renal dopamine production by increasing the renal tubular uptake of l-DOPA.

Authors:  Xiaoliang Jiang; Yanrong Zhang; Yu Yang; Jian Yang; Laureano D Asico; Wei Chen; Robin A Felder; Ines Armando; Pedro A Jose; Zhiwei Yang
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-10-25       Impact factor: 4.310

8.  Exposure to Maternal Diabetes Mellitus Causes Renal Dopamine D1 Receptor Dysfunction and Hypertension in Adult Rat Offspring.

Authors:  Hao Luo; Caiyu Chen; Li Guo; Zaicheng Xu; Xiaoyu Peng; Xinquan Wang; Jialiang Wang; Na Wang; Chuanwei Li; Xiaoli Luo; Hongyong Wang; Pedro A Jose; Chunjiang Fu; Yu Huang; Weibin Shi; Chunyu Zeng
Journal:  Hypertension       Date:  2018-10       Impact factor: 10.190

Review 9.  Kidney tubules: intertubular, vascular, and glomerular cross-talk.

Authors:  David A Ferenbach; Joseph V Bonventre
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-05       Impact factor: 2.894

Review 10.  Modulation of polycystic kidney disease by G-protein coupled receptors and cyclic AMP signaling.

Authors:  Caroline R Sussman; Xiaofang Wang; Fouad T Chebib; Vicente E Torres
Journal:  Cell Signal       Date:  2020-04-23       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.